NetworkNewsBreaks

FridayJun 29, 2018 11:37 am

NetworkNewsBreaks – Zenosense, Inc. (ZENO) Developing Technology to Deliver High-sensitivity Laboratory Accuracy in Emergency Settings

Healthcare technology company Zenosense (OTC: ZENO) is currently developing its MIDS Cardiac handheld diagnostic technology to provide rapid cardiac biomarker tests in emergency settings. A recent article discussing the company reads: “MIDS goes beyond the optical technology used by most immunoassay tests. The analytical sensitivity gap between central laboratory testing platforms and existing POC testing devices is significant as this bulky optical technology has not been successfully miniaturized into high sensitivity capable, handheld devices. In contrast, the MIDS technology uses highly sensitive, custom-built “Hall Effect” magnetic sensors that allow it to detect extremely low levels of magnetic field disturbance caused…

Continue Reading

FridayJun 29, 2018 11:31 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Takes Cutting-edge Approach to Intelligent Payment Solutions

Global technology and value-added solutions group Net Element’s (NASDAQ: NETE) subsidiary, Unified Payments, provides a suite of solutions that keep service to the customer flowing “any time, any place, any payment”. An article discussing the innovative solutions reads: “Payment solutions provider Net Element has developed an expertise in linking mobile phones, brick and mortar stores, banks and unbanked web-based businesses to deliver reliable multi-channel possibilities to buyers and transaction analysis to the businesses who serve them. The company’s recent announcement that its subsidiary, Unified Payments, is launching an intelligent payment solution for the events industry (http://nnw.fm/8fWQp) is an example of…

Continue Reading

FridayJun 29, 2018 9:54 am

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Adds Three New Products to Full Spectrum CBD Chocolate Line

Innovative biotech company Earth Science Tech (OTC: ETST) this morning announced that it is expanding its full spectrum cannabinoid (“CBD”) chocolate line with three unique new products formulated with the company’s joint venture partner, Karmavore Superfoods. The new products, Raw Dark Chocolate Covered Mangoes, Raw Dark Chocolate Coconut Peppermint Cups, and Raw Dark Chocolate Caramelized Quinoa Crunch, bring the company’s total to five unique CBD Raw Chocolate flavors. Production of the new products is currently underway and ETST anticipates a successful launching within the third quarter of 2018. “Our joint venture with Karmavore Superfoods has been a true blessing. Brian…

Continue Reading

FridayJun 29, 2018 9:31 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Adds Prem Virmani as Chair of Beverage Science and Research Division

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that Prem Virmani, former senior vice president of global science and research for Cott Beverages, Inc., has been appointed Chair of TGOD’s Beverage Science and Research Division. Per the update, Virmani has over four decades of applicable industry experience, leading development in every major category, including the Sam’s Choice cola program for Walmart, the President’s Choice cola program for Loblaws and other major private label brands for Publix, Wegmans and Safeway. “I am delighted that Prem has joined the TGOD Leadership team,”…

Continue Reading

FridayJun 29, 2018 9:27 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application Following Breakthrough Discovery of Enhanced Drug Delivery to Brain Tissue

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has filed a new patent application with the United States Patent and Trademark Office ("USPTO") for innovation in treatment options related to central nervous system disease or disorders including viral infection, cancer, neurodegenerative disorders, ADHD, anxiety, depression, OCD, schizophrenia, Alzheimer's, Huntington's, Parkinson's, neuropathic pain and more. The company reached a breakthrough discovery during recent laboratory testing that demonstrated significantly enhanced drug delivery to brain tissue. Evidence from the study showed unexpected effectiveness in crossing the blood-brain barrier ("BBB") which Lexaria is investigating more extensively, leading to the company's…

Continue Reading

ThursdayJun 28, 2018 2:58 pm

NetworkNewsBreaks – Consorteum Holdings, Inc.’s (CSRH) Technology Boasts Potential to Assist Rapidly Developing Markets

Consorteum Holdings (OTC: CSRH) is a software development and mobile solutions company that is positioned for growth with its innovative technology offerings. An article discussing the company reads: “CSRH is a software development and mobile publishing company, with its primary focus in the mobile gaming sector. The company plans to release its first global sports app in 2018, offering massive amounts of compiled historical data and updates on cricket teams and players. With 2.5 billion worldwide cricket fans, this first predictive data analytics mobile offering will provide CSRH with an excellent position as it enters the gaming sector. … The…

Continue Reading

ThursdayJun 28, 2018 2:52 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Continues to Build Patent Portfolio

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is in the process of preparing new patent application filings and expects to receive more patent awards this year to add to its collection of over 40 patent awards or applications from 40 countries globally. A recent article discussing the company reads: “The total, once granted, would be four patents in the U.S. and four in Australia. All eight are for the family of “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof.” The development represents the first time that LXRP has expanded its patent protection outside of…

Continue Reading

ThursdayJun 28, 2018 1:25 pm

NetworkNewsBreaks – Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Announces Completion of Drilling Program at San Roque

Mineral exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) today announced that it has successfully completed its previously detailed diamond core drilling program at the San Roque property in the Rio Negro province of Argentina. The property is held by Minas San Roque S.A., which is jointly owned by Marifil’s wholly owned subsidiary, Marifil Mines S.A. (51 percent), and Novagold Resources Inc.’s (TSX: NG) wholly owned subsidiary, NovaGold Argentina Inc. (49 percent). Marifil serves as the project operator. Per the update, the program consisted of four drill holes for a total of 846.5 meters. “This drilling campaign was nicely…

Continue Reading

ThursdayJun 28, 2018 11:49 am

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Innovative Therapies as Alternative Medicine Market Surges

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing pioneering options for preventive and curative therapies by utilizing several creative pathways. An article further discussing the company reads: “Chronic diseases and recurring health care issues are taking an increasingly bigger piece of the economic pie and disrupting the lives of many millions of people. U.S. health care costs for chronic diseases totaled $1.1 trillion in 2016 and balloon to $3.7 trillion when lost economic productivity is calculated into the total economic impact. According to a new report by Grand View Research, people around the world, along with their…

Continue Reading

ThursdayJun 28, 2018 11:39 am

NetworkNewsBreaks – Why Koios Beverage Corp. (CSE: KBEV) is “One to Watch”

Koios Beverage (CSE: KBEV) develops and distributes nature-based products such as nootropics, which are supplements that improve cognitive abilities. An article further discussing the company reads: “Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024. … According to media reports, there is believed…

Continue Reading